Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: A planned safety analysis in 1,864 patients

Hans-Joachim Schmoll, Thomas Cartwright, Josep Tabernero, Marek P Nowacki, Arie Figer, Jean Maroun, Timothy Price, Robert Lim, Eric Van Cutsem, Young-Suk Park, Joseph McKendrick, Claire Topham, Gemma Soler-Gonzalez, Filipo de Braud, Mark Hill, Florin Sirzen, Daniel G Haller

Research output: Contribution to journalArticleResearchpeer-review

238 Citations (Scopus)

Abstract

To report the results of a planned safety analysis from a phase III trial comparing capecitabine plus oxaliplatin (XELOX) with bolus fluorouracil/leucovorin (FU/LV) as adjuvant therapy for stage III colon cance
Original languageEnglish
Pages (from-to)102 - 109
Number of pages8
JournalJournal of Clinical Oncology
Volume25
Issue number1
DOIs
Publication statusPublished - 2007

Cite this